Infliximab as a treatment for recalcitrant pyoderma gangrenosum
- 27 February 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 29 (2) , 196-197
- https://doi.org/10.1111/j.1365-2230.2004.01470.x
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Favorable Response to Infliximab Treatment in a Patient with Active Crohn Disease and Pyoderma GangrenosumScandinavian Journal of Gastroenterology, 2002
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritisThe Lancet, 1994